FI94093B - Förfarande för lyofilisering av ett levande herpesvirusvaccin - Google Patents

Förfarande för lyofilisering av ett levande herpesvirusvaccin

Info

Publication number
FI94093B
FI94093B FI882041A FI882041A FI94093B FI 94093 B FI94093 B FI 94093B FI 882041 A FI882041 A FI 882041A FI 882041 A FI882041 A FI 882041A FI 94093 B FI94093 B FI 94093B
Authority
FI
Finland
Prior art keywords
lyophilization
procedure
herpes virus
virus vaccine
live herpes
Prior art date
Application number
FI882041A
Other languages
English (en)
Finnish (fi)
Other versions
FI882041A0 (sv
FI882041A (sv
FI94093C (sv
Inventor
William J Mcaleer
Henry Z Markus
Robert Z Maigetter
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of FI882041A0 publication Critical patent/FI882041A0/sv
Publication of FI882041A publication Critical patent/FI882041A/sv
Publication of FI94093B publication Critical patent/FI94093B/sv
Application granted granted Critical
Publication of FI94093C publication Critical patent/FI94093C/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/245—Herpetoviridae, e.g. herpes simplex virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/245—Herpetoviridae, e.g. herpes simplex virus
    • A61K39/25—Varicella-zoster virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0015—Combination vaccines based on measles-mumps-rubella
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
    • C12N2710/16734—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
FI882041A 1987-05-04 1988-05-02 Förfarande för lyofilisering av ett levande herpesvirusvaccin FI94093C (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US4594087A 1987-05-04 1987-05-04
US4594087 1987-05-04

Publications (4)

Publication Number Publication Date
FI882041A0 FI882041A0 (sv) 1988-05-02
FI882041A FI882041A (sv) 1988-11-05
FI94093B true FI94093B (sv) 1995-04-13
FI94093C FI94093C (sv) 1995-07-25

Family

ID=21940663

Family Applications (1)

Application Number Title Priority Date Filing Date
FI882041A FI94093C (sv) 1987-05-04 1988-05-02 Förfarande för lyofilisering av ett levande herpesvirusvaccin

Country Status (16)

Country Link
EP (1) EP0290197B1 (sv)
JP (1) JP2643982B2 (sv)
KR (1) KR960016581B1 (sv)
AT (1) ATE95427T1 (sv)
AU (1) AU622110B2 (sv)
CA (1) CA1324956C (sv)
DE (1) DE3884663T2 (sv)
DK (1) DK238688A (sv)
FI (1) FI94093C (sv)
HK (1) HK5997A (sv)
IE (1) IE61575B1 (sv)
IL (1) IL86180A (sv)
NO (1) NO176163C (sv)
NZ (1) NZ224419A (sv)
PT (1) PT87388B (sv)
ZA (1) ZA883133B (sv)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2000034A6 (es) * 1985-11-26 1987-10-01 Schweiz Serum & Impfinst Procedimiento para la preparacion de una vacuna viva contra paperas
IL120202A (en) 1996-03-07 2001-03-19 Akzo Nobel Nv Container with freeze-dried vaccine components
GB9808922D0 (en) 1998-04-24 1998-06-24 Cantab Pharmaceuticals Res Ltd Virus preparations
US6592869B2 (en) 1999-08-24 2003-07-15 Teva Pharmaceutical Industries, Ltd. Vaccine composition and method of using the same
ES2605109T3 (es) 1999-08-24 2017-03-13 Abic Biological Laboratories Ltd. Composición de vacuna y procedimiento de uso de la misma
CA2668834C (en) 2006-11-07 2016-10-11 Sanofi Pasteur Biologics Co. Stabilization of vaccines by lyophilization
CN103796683A (zh) * 2011-04-21 2014-05-14 塔夫茨大学信托人 用于活性试剂稳定化的方法和组合物
AU2019414450A1 (en) * 2018-12-27 2021-06-17 Amgen Inc. Lyophilized virus formulations

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5341202B2 (sv) * 1974-03-12 1978-11-01
GB1481650A (en) * 1975-05-06 1977-08-03 Merck & Co Inc Chemical processes and products
US4273762A (en) * 1979-12-03 1981-06-16 Merck & Co., Inc. Lyophilization process for live viral compositions
US4859587A (en) * 1984-06-04 1989-08-22 Institut Merieux Recombinant herpes simplex viruses, vaccines and methods
JPS6314729A (ja) * 1986-06-30 1988-01-21 スミスクライン・バイオロジカルス・ソシエテ・アノニム 生ワクチン用改良安定剤、その製造法およびそれを含有するワクチン

Also Published As

Publication number Publication date
FI882041A0 (sv) 1988-05-02
NO176163C (no) 1995-02-15
PT87388A (pt) 1989-05-31
HK5997A (en) 1997-01-17
DE3884663T2 (de) 1994-04-07
EP0290197B1 (en) 1993-10-06
NO881931L (no) 1988-11-07
CA1324956C (en) 1993-12-07
KR960016581B1 (ko) 1996-12-16
EP0290197A2 (en) 1988-11-09
DK238688D0 (da) 1988-05-03
DK238688A (da) 1988-11-05
ZA883133B (en) 1988-11-08
NO176163B (no) 1994-11-07
IL86180A0 (en) 1988-11-15
AU622110B2 (en) 1992-04-02
KR880013575A (ko) 1988-12-21
IE61575B1 (en) 1994-11-16
DE3884663D1 (de) 1993-11-11
NZ224419A (en) 1991-03-26
IL86180A (en) 1992-08-18
NO881931D0 (no) 1988-05-03
AU1552788A (en) 1988-11-10
ATE95427T1 (de) 1993-10-15
JP2643982B2 (ja) 1997-08-25
EP0290197A3 (en) 1989-10-18
PT87388B (pt) 1992-08-31
FI882041A (sv) 1988-11-05
IE881248L (en) 1988-11-04
JPS646220A (en) 1989-01-10
FI94093C (sv) 1995-07-25

Similar Documents

Publication Publication Date Title
FI893929A0 (sv) Förfarande för framställning av ett stabilt zink-protamin- -interferonkomplex
FI95255C (sv) Förfarande för framställning av nya terapeutiskt användbara merkaptoacetylamidopyrrolo- och -pyridobensazepinderivat
DE3751811D1 (de) LH-RH-Analoga enthaltende Formulierungen
FR2620459B1 (fr) Virus recombinant de la vaccine
FI94093B (sv) Förfarande för lyofilisering av ett levande herpesvirusvaccin
FI843141A (fi) Nya tillvaexthormon-frigoerande peptider och foerfarande foer behandling av daeggdjur med desamma.
EP0295043A3 (en) Stabilized live attenuated vaccine and its production
JPS5692822A (en) Method of freeze drying live virus composition
ES2058176T3 (es) Un procedimiento para preparar un derivado peptidico.
ES2054732T3 (es) Un procedimiento para preparar un derivado peptidico.
FI945626A (sv) Förfarande för framställning av 2,2-difluor-ketensilylacetaler och alfa, alfa-difluor-beta-silyloxi-1,3-dioxolan-4-propansyraestrar
DK331087D0 (da) Stabilisator for levende vaccine
NO883520D0 (no) Fremgangsmaate for fremstilling av et injeksjonspreparat.
FI893682A (sv) Förfarande för framställning av en terapeutiskt användbar 1,2,5-ditiazocinderivat
ATE90878T1 (de) Avirulenter tollwut-impfstoff.
ES2011442T3 (es) Gametocidas.
PT96807A (pt) Processo melhorado para a sintese de analogos de lh-rh (hormona de libertacao da hormona de luteinizacao) com proteccao minima temporaria
ATA245087A (de) Foerdergeblaese fuer erntegut
KR880017238U (ko) 신발깔창 부착용 공기주입기
NZ186929A (en) Stabilized live virus vaccine

Legal Events

Date Code Title Description
BB Publication of examined application
FG Patent granted

Owner name: MERCK & CO., INC.

MA Patent expired